Exhibit 10.2
CONSULTING AGREEMENT
THIS CONSULTING AGREEMENT (the
“Agreement”) is made as of the 2nd day of March, 2009
(the “Effective Date”), and is by and between Anavex
Life Sciences Corp. A Nevada State Corporation with an office at 27
Marathonos Ave. Pallini, Greece (hereinafter
“Company”), and Tariq Arshad , with an address
at 25 Sussex Lane, East Windsor, NJ, USA (Hereinafter
“Consultant”).
W I T N E S S E T H:
WHEREAS the Consultant has developed considerable expertise
in the Field of Business Development specific to
biotech.
WHEREAS the Company wishes to engage the services of the
Consultant to assist the Company in identifying Business
opportunities and Strategic Development.
AND WHEREAS Consultant wishes to perform such services among
others for and on behalf of the Company and the Company desires to
obtain and apply the expertise of the Consultant to the Business of
the Company.
NOW THEREFORE THIS AGREEMENT WITNESSES that for good and
valuable consideration (the receipt of which is hereby acknowledged
by each of the parties hereto) the parties make the arrangements
and acknowledgements hereinafter set forth:
1.
Consulting Services - The Company hereby retains the
services of the Consultant and the Consultant hereby agrees to
provide the consulting services (the “Services”) to the
Company described in this Agreement, by providing such Services to
benefit the Company and its determination and implementation of the
Company's plans for its Business.
2.
Term - This Agreement is effective as of the
Effective Date and shall remain in force, for a period of 1 (one)
year.
3.
Termination
|
3.1
|
Either party may at any time
terminate this Agreement by providing the other party with at least
thirty (30) days written notice.
|
|
|
|
|
3.2
|
Upon termination of this
Agreement, Consultant shall return to the Company all material that
is the property of the Company.
|
- 2 -
|
3.3
|
Upon termination the Consultant
shall have 30 days to exercise any options that have already
vested. After 30 days any unexercised options shall become void and
of no further effect. All non-vested options at the time of
termination or death shall become immediately void and of no
further effect.
|
4.
Compensation - In full consideration of the
Consultant's Services hereunder, the Company shall compensate the
Consultant a fee as follows:
|
|
a.
|
Issue to the Consultant 5,000
Share purchase options subject to Schedule 1 as
attached.
|
IN WITNESS WHEREOF, each of the parties hereto has executed
as of the date first herein above written.
COMPANY:
Anavex Life Sciences
Corp.
By: “Harvey
Lalach”
Harvey Lalach
President
CONSULTANT:
“
Tariq
Arshad”
Tariq Arshad
SCHEDULE 1
STOCK OPTION AGREEMENT
This Stock Option Agreement is made as of March 2, 2009 by and
between Anavex Life Sciences Corp. (the “Corporation”),
and Tariq Arshad (the “Optionee”).
RECITALS
A. The Corporation and the Optionee have entered into a
Consulting Agreement dated as of March 2, 2009 (the
“Consulting Agreement”) that provides for the grant of
stock options to
